Press Releases News Year None202020192018201720162015201420132012 Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 | Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference Mar 06, 2019 | Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results Feb 26, 2019 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 | Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 | Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors Jan 02, 2019 | Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors Dec 12, 2018 | Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration Nov 12, 2018 | Ophthotech Reports Third Quarter 2018 Financial and Operating Results Oct 31, 2018 | Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 | Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 |
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 |
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors Jan 02, 2019 |
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors Dec 12, 2018 |
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration Nov 12, 2018 |
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 |
Press Releases News Year None202020192018201720162015201420132012 Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 | Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference Mar 06, 2019 | Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results Feb 26, 2019 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 | Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 | Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors Jan 02, 2019 | Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors Dec 12, 2018 | Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration Nov 12, 2018 | Ophthotech Reports Third Quarter 2018 Financial and Operating Results Oct 31, 2018 | Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 | Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 |
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 |
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors Jan 02, 2019 |
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors Dec 12, 2018 |
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration Nov 12, 2018 |
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 |
